Company: PFSA
Filing Date: 2025-05-09
Form Type: S-4/A
Source: 0001213900-25-041151
Chunk: 368

Company: Profusa, Inc.
Filing Date: 2025-05-09
Form: S-4/A
Chunk 368
---
1,000,000 |   |     |            |  1,000,000 |   |
|                                                                                         |     |                   | 33,002,012 |   |     |            | 32,949,853 |   |

____________ (1)The weighted average common shares outstanding include (a) outstanding convertible preferred stock of Profusa, which is entitled to the same per share merger consideration as Profusa common stock on an as converted to common stock basis, and (b) common stock of New Profusa issuable upon the conversion of junior convertible notes and senior convertible notes of Profusa. The following potential shares were excluded from the calculation of diluted net loss per share:

|                                                    |     |        As of 
 December 31, 
         2024 |     |        As of 
 December 31, 
         2023 |
|:---------------------------------------------------|:----|-------------:|:----|-------------:|
| Shares underlying NorthView’s outstanding warrants |     |   17,404,250 |     |   17,404,250 |
| Milestone Earnout Shares                           |     |    3,875,000 |     |    3,875,000 |
| Outstanding Profusa options                        |     |      855,508 |     |      937,395 |
| Sponsor Inducement Recoupment Shares               |     |            — |     |            — |
| Profusa Inducement Recoupment Shares               |     |            — |     |            — |
|                                                    |     |   22,134,758 |     |   22,216,645 |

•Shares underlying NorthView’s outstanding warrants are not included in the calculation of diluted net loss per share because these shares are contingently issuable, and the contingencies have not yet been met. •Milestone Earnout Shares are not included in the calculation of diluted net loss per share because these shares are contingently issuable, and the contingencies have not yet been met.

194 •Outstanding Profusa options are anti -dilutiveand are not included in the calculation of diluted net loss per share. •Sponsor Inducement Recoupment Shares are excluded because they are expected to be forfeited by the Sponsor upon the closing of the Merger. •Profusa Inducement Recoupment Shares are excluded because they are expected to be forfeited by the Sponsor upon the closing of the Merger. 195 COMPARATIVE PER SHARE DATA